During the past decade, Prisma Health Cancer Institute - Greer conducted 167 clinical trials. In the 10-year time frame, 167 clinical trials started and 117 clinical trials were completed, i.e. on average, 70.1% percent of trials that started reached the finish line to date. In the past 5 years, 57 clinical trials started and 75 clinical trials were completed. i.e. 131.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Prisma Health Cancer Institute - Greer" #1 sponsor was "National Cancer Institute (NCI)" with 100 trials, followed by "Alliance for Clinical Trials in Oncology" with 52 trials sponsored, "SWOG Cancer Research Network" with 51 trials sponsored, "NRG Oncology" with 17 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 17 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Prisma Health Cancer Institute - Greer" #1 collaborator was "National Cancer Institute (NCI)" with 167 trials as a collaborator, "NRG Oncology" with 26 trials as a collaborator, "Canadian Cancer Trials Group" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "NCIC Clinical Trials Group" with 5 trials as a collaborator. Other collaborators include 50 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "Prisma Health Cancer Institute - Greer" are "Breast Cancer" (17 trials), "Colorectal Cancer" (8 trials), "Stage IV Lung Cancer AJCC v8" (8 trials), "Invasive Breast Carcinoma" (7 trials) and "Stage II Breast Cancer" (7 trials). Many other conditions were trialed in "Prisma Health Cancer Institute - Greer" in a lesser frequency.

Most popular intervention types in "Prisma Health Cancer Institute - Greer" are "Drug" (206 trials), "Other" (178 trials), "Biological" (88 trials), "Procedure" (57 trials) and "Radiation" (54 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (73 trials), "Quality-of-Life Assessment" (69 trials), "Questionnaire Administration" (48 trials), "Cisplatin" (31 trials) and "Carboplatin" (25 trials). Other intervention names were less common.

The vast majority of trials in "Prisma Health Cancer Institute - Greer" are 215 trials for "All" genders, 44 trials for "Female" genders and 15 trials for "Male" genders.

Currently, there are NaN active trials in "Prisma Health Cancer Institute - Greer". undefined are not yet recruiting, 61 are recruiting, 127 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 63 completed trials in Prisma Health Cancer Institute - Greer, 6 suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Prisma Health Cancer Institute - Greer, 6 "Phase 1" clinical trials were conducted, 111 "Phase 2" clinical trials and 142 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 17 trials that are defined as “Not Applicable".